Caprock Group LLC Purchases New Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Caprock Group LLC purchased a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 11,611 shares of the pharmacy operator’s stock, valued at approximately $140,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Acadian Asset Management LLC increased its stake in shares of Walgreens Boots Alliance by 1,444.1% in the 2nd quarter. Acadian Asset Management LLC now owns 15,456 shares of the pharmacy operator’s stock valued at $186,000 after purchasing an additional 14,455 shares in the last quarter. Savant Capital LLC increased its stake in Walgreens Boots Alliance by 59.1% during the 2nd quarter. Savant Capital LLC now owns 69,631 shares of the pharmacy operator’s stock worth $842,000 after buying an additional 25,868 shares in the last quarter. Foundry Partners LLC purchased a new stake in Walgreens Boots Alliance during the 2nd quarter worth approximately $467,000. TD Asset Management Inc increased its stake in Walgreens Boots Alliance by 24.9% during the 2nd quarter. TD Asset Management Inc now owns 379,029 shares of the pharmacy operator’s stock worth $4,584,000 after buying an additional 75,557 shares in the last quarter. Finally, Belpointe Asset Management LLC increased its stake in Walgreens Boots Alliance by 648.5% during the 2nd quarter. Belpointe Asset Management LLC now owns 144,384 shares of the pharmacy operator’s stock worth $1,746,000 after buying an additional 125,094 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Analyst Upgrades and Downgrades

WBA has been the subject of several research reports. Truist Financial cut their price objective on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a research note on Friday, June 28th. Royal Bank of Canada cut their price objective on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research note on Tuesday, July 2nd. Evercore ISI cut their price objective on Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating for the company in a research note on Friday, June 28th. UBS Group lowered their target price on Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a report on Wednesday, July 3rd. Finally, Bank of America lowered their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a report on Wednesday, September 4th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average price target of $14.73.

Get Our Latest Analysis on Walgreens Boots Alliance

Walgreens Boots Alliance Trading Up 4.2 %

WBA opened at $9.21 on Friday. The stock has a market capitalization of $7.95 billion, a PE ratio of -1.37, a P/E/G ratio of 0.98 and a beta of 0.70. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. Walgreens Boots Alliance, Inc. has a one year low of $8.46 and a one year high of $27.05. The business’s 50 day moving average price is $10.51 and its 200 day moving average price is $15.15.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). The firm had revenue of $36.40 billion during the quarter, compared to analysts’ expectations of $35.94 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The firm’s revenue for the quarter was up 2.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.00 EPS. As a group, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 2.87 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st were given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 10.86%. The ex-dividend date of this dividend was Wednesday, August 21st. Walgreens Boots Alliance’s payout ratio is -14.84%.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.